Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis

B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit

(2014) J.-B. Sun et al.   JOURNAL OF IMMUNOLOGY

TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity

(2014) V. Lampropoulou et al.   JOURNAL OF IMMUNOLOGY

Rituximab for the Treatment of Non-Hodgkinʼs Lymphoma and Chronic Lymphocytic Leukaemia

(2010) Fredrick Hagemeister   DRUGS

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

(2010) Paul A. Blair et al.   IMMUNITY

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders

(2009) M. C. Levesque   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Rituximab-induced vasculitis: A case report and review of the medical published work

(2009) Min Joo KIM et al.   JOURNAL OF DERMATOLOGY

Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice

(2009) P. A. Blair et al.   JOURNAL OF IMMUNOLOGY

B-cell-depletion therapy in SLE—what are the current prospects for its acceptance?

(2009) Catarina Favas et al.   Nature Reviews Rheumatology

B-Cell–Depleting Induction Therapy and Acute Cellular Rejection

(2009) Menna R. Clatworthy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma

(2008) F Mielke et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

(2008) B. Godeau et al.   BLOOD

Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients

(2008) G. J. Silverman et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström’s macroglobulinemia

(2008) Aisha Shaikh et al.   Clinical and Experimental Nephrology

Cytokine-producing B lymphocytes—key regulators of immunity

(2008) Frances E Lund   CURRENT OPINION IN IMMUNOLOGY

B-Cells Promote Intra-Islet CD8+ Cytotoxic T-Cell Survival to Enhance Type 1 Diabetes

(2008) G. M. Brodie et al.   DIABETES

Rituximab in relapsing Graves' disease, a phase II study

(2008) Karen A Heemstra et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses

(2008) Koichi Yanaba et al.   IMMUNITY

Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression

(2008) Takashi Matsushita et al.   JOURNAL OF CLINICAL INVESTIGATION

B-cell Depletion Using an Anti-CD20 Antibody Augments Antitumor Immune Responses and Immunotherapy in Nonhematopoetic Murine Tumor Models

(2008) Samuel Kim et al.   JOURNAL OF IMMUNOTHERAPY

Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma

(2008) Xin Liu et al.   LEUKEMIA & LYMPHOMA

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab-Induced Hypersensitivity Pneumonitis

(2008) Adriano R. Tonelli et al.   RESPIRATION

Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus

(2008) K. Suzuki et al.   RHEUMATOLOGY